Department of Health
and Human Services (HHS)
and Human Services (HHS)
PAR-19-329: Clinical Coordinating Center for Multi-Site Investigator-Initiated Clinical Trials (Collaborative UG3/UH3 Clinical Trial Required)
PAR-19-330: Data Coordinating Center for Multi-Site Investigator-Initiated Clinical Trials (Collaborative U24 Clinical Trial Required)
National Heart, Lung, and Blood Institute (NHLBI)
The purpose of this Notice is to inform potential applicants that NHLBI has posted a set of responses to Frequently Asked Questions (FAQs) regarding Multi-Site Investigator-Initiated Clinical Trials for PAR-19-329: Clinical Coordinating Center for Multi-Site Investigator-Initiated Clinical Trials (Collaborative UG3/UH3 Clinical Trial Required) and PAR-19-330: Data Coordinating Center for Multi-Site Investigator-Initiated Clinical Trials (Collaborative U24 Clinical Trial Required). The FAQs are available on the NHLBI website at the following link: https://www.nhlbi.nih.gov/grants-and-training/funding-opportunities/foa-Investigator-Initiated-Multi-Site-Clinical-Trials-FAQ.
Applicants are strongly encouraged to review the FAQs, which may be updated at any time without additional notice, prior to submitting their application.
Scientific/Research Contact(s)
Division of Blood Diseases and Resources
Nancy DiFronzo, PhD
National Heart, Lung, and Blood Institute (NHLBI)
Telephone: 301-435-0065
Email: [email protected]
Division of Cardiovascular Sciences
Yves Rosenberg, MD, MPH
National Heart, Lung, and Blood Institute (NHLBI)
Telephone: 301-435-0550
Email: [email protected]
Division of Lung Diseases
Gail Weinmann, MD
National Heart, Lung, and Blood Institute (NHLBI)
Telephone: 301-435-0233
Email: [email protected]
Peer Review Contact(s)
Keary A. Cope, PhD
National Heart, Lung, and Blood Institute (NHLBI)
Telephone: 301-435-0287
Email: [email protected]
Financial/Grants Management Contact(s)
Anthony Agresti
National Heart, Lung, and Blood Institute (NHLBI)
Telephone: 301-827-8014
Email: [email protected]